Zhang, Z.; Xie, T.; Qi, C.; Zhang, X.; Shen, L.; Peng, Z.
Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors. Cancers 2022, 14, 3736.
https://doi.org/10.3390/cancers14153736
AMA Style
Zhang Z, Xie T, Qi C, Zhang X, Shen L, Peng Z.
Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors. Cancers. 2022; 14(15):3736.
https://doi.org/10.3390/cancers14153736
Chicago/Turabian Style
Zhang, Zhening, Tong Xie, Changsong Qi, Xiaotian Zhang, Lin Shen, and Zhi Peng.
2022. "Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors" Cancers 14, no. 15: 3736.
https://doi.org/10.3390/cancers14153736
APA Style
Zhang, Z., Xie, T., Qi, C., Zhang, X., Shen, L., & Peng, Z.
(2022). Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors. Cancers, 14(15), 3736.
https://doi.org/10.3390/cancers14153736